609 F. App'x 295
6th Cir.2015Background
- Anmy Tran, a Michigan podiatrist, was convicted for participating in a healthcare-fraud conspiracy run by Babubhai Patel, who paid bribes and kickbacks to generate prescriptions billed to Medicare, Medicaid, and private insurers.
- Patel paid Tran upfront and monthly contributions; in return Tran prescribed combinations of a controlled pain medication (often hydrocodone) plus multiple high-margin non-controlled drugs; prescriptions were then filled at Patel’s Highland Park Pharmacy, which shorted non-controlled drugs and billed insurers for full quantities.
- Tran accepted street-recruited patients and continued prescribing to known or suspected “doctor shoppers”; she also referred patients to Patel’s home-healthcare companies for kickbacks.
- At trial Tran was convicted of conspiracy to commit healthcare fraud, conspiracy to distribute controlled substances, and conspiracy to pay/receive healthcare kickbacks; the district court denied post-trial relief.
- The PSR attributed $4,475,193.40 in loss to Tran and 213,548 units of hydrocodone; the district court adopted these findings, set a guidelines range of 97–121 months, then varied downward and sentenced Tran to 60 months.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Admissibility of comparative prescription statistics under Fed. R. Evid. 403 | Statistics show probative comparison and support fraud theory | Tran: statistics unfairly prejudicial and could lead jury to convict based on volume alone | Court: no abuse of discretion; statistics were probative and supported by other evidence; Rule 403 balance affirmed |
| Admissibility/scope of pharmacist expert testimony under Fed. R. Evid. 702 | Gov: pharmacist can testify about ethical/legal pharmacy duties and identify “red flags” in prescriptions | Tran: pharmacist lacked physician training to judge medical necessity; testimony intruded on medical judgment | Court: expert testimony admissible; pharmacist’s training qualified him to identify suspicious prescriptions and explain basis for those opinions |
| Drug-quantity attribution for guideline calculation | Gov: all hydrocodone units prescribed and filled at Highland Park attributable to conspiracy | Tran: not all units were unlawfully distributed; record doesn’t show lack of medical necessity for all | Court: no clear error; reasonable inferences and extrapolation supported finding of >100,000 units, so guideline level unaffected |
| Amount-of-loss calculation for guideline enhancement | Gov: PSR’s loss estimate (>$4.4M) reasonable; at least $1.7M tied to Medicare prescriptions fits loss threshold | Tran: government failed to prove each billed prescription caused insurer loss | Court: at least $1,711,499.65 supported on record; district court’s reasonable estimate not clearly erroneous and any error was harmless |
Key Cases Cited
- United States v. Patel, [citation="579 F. App'x 449"] (6th Cir. 2014) (describing Patel-organized pharmacy fraud scheme)
- United States v. Davis, 514 F.3d 596 (6th Cir. 2008) (abuse-of-discretion review for evidentiary rulings)
- United States v. Weinstock, 153 F.3d 272 (6th Cir. 1998) (upholding comparative statistics in podiatrist prosecution)
- United States v. McKay, 715 F.3d 807 (10th Cir. 2013) (cautioning Rule 403 use of prescribing-statistics in some cases)
- United States v. Swanberg, 370 F.3d 622 (6th Cir. 2004) (standards for reviewing drug-quantity findings)
- United States v. Leal, 75 F.3d 219 (6th Cir. 1996) (permitting reasonable inferences at sentencing on drug quantities)
- United States v. Poulsen, 655 F.3d 492 (6th Cir. 2011) (district court must provide reasonable estimate of loss; clear-error review)
- United States v. Washington, 715 F.3d 975 (6th Cir. 2013) (defendant bears burden to prove fair-market value of services rendered to reduce loss)